Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage-small Cell Lung Cancer”

583 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 583 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07022301
What this trial is testing

Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy

Who this might be right for
Small Cell Lung Cancer Extensive StageResistance to Immunotherapy
First Affiliated Hospital of Wannan Medical College 25
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)Study completedNCT01439568
What this trial is testing

LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma

Who this might be right for
Extensive Stage Small Cell Lung Carcinoma
Eli Lilly and Company 90
Testing effectiveness (Phase 2)Looking for participantsNCT06362252
What this trial is testing

I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

Who this might be right for
Extensive Stage-small Cell Lung Cancer
Daiichi Sankyo 123
Testing effectiveness (Phase 2)Study completedNCT00869752
What this trial is testing

MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 12
Testing effectiveness (Phase 2)Study completedNCT00004055
What this trial is testing

Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 38
Testing effectiveness (Phase 2)Study completedNCT02945852
What this trial is testing

Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.

Who this might be right for
Small Cell Lung Cancer
Fan Yun, MD 40
Testing effectiveness (Phase 2)UnknownNCT02972320
What this trial is testing

Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Yunpeng Liu 60
Not applicableStudy completedNCT04854590
What this trial is testing

IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Carcinoma, Small Cell
AstraZeneca 248
Testing effectiveness (Phase 2)Looking for participantsNCT05718323
What this trial is testing

Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC

Who this might be right for
SCLC,Extensive StageSLFN11-positive
ETOP IBCSG Partners Foundation 44
Not applicableStudy completedNCT00303901
What this trial is testing

Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

Who this might be right for
Lung CancerMetastatic Cancer
Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07172412
What this trial is testing

Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell Cancer
Tianjin Medical University Cancer Institute and Hospital 165
Early research (Phase 1)WithdrawnNCT06427369
What this trial is testing

An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung CancerLimited-stage Small-cell Lung CancerLung Non-Small Cell Carcinoma+2 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05882630
What this trial is testing

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Fujian Cancer Hospital 39
Testing effectiveness (Phase 2)Looking for participantsNCT05924841
What this trial is testing

BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT00009971
What this trial is testing

Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Institute (NCI) 32
Early research (Phase 1)Looking for participantsNCT06807632
What this trial is testing

Valemetostat in Combination With Atezolizumab in People With Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Memorial Sloan Kettering Cancer Center 24
Not applicableLooking for participantsNCT06717243
What this trial is testing

Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)

Who this might be right for
Small Cell Lung CancerLarge Cell Neuroendocrine (NE) TumorsTreatment Failure+3 more
Oncology Center of Biochemical Education And Research 111
Large-scale testing (Phase 3)UnknownNCT04234607
What this trial is testing

TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)

Who this might be right for
Extensive Small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 738
Testing effectiveness (Phase 2)UnknownNCT00014547
What this trial is testing

BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Lung Cancer
Theradex
Load More Results